chr11-128839377-G-T
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PVS1_StrongPP5_Very_Strong
The NM_153766.3(KCNJ1):c.867C>A(p.Cys289*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000279 in 1,614,042 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_153766.3 stop_gained
Scores
Clinical Significance
Conservation
Publications
- Bartter disease type 2Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- antenatal Bartter syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| KCNJ1 | NM_153766.3 | c.867C>A | p.Cys289* | stop_gained | Exon 3 of 3 | ENST00000392666.6 | NP_722450.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| KCNJ1 | ENST00000392666.6 | c.867C>A | p.Cys289* | stop_gained | Exon 3 of 3 | 1 | NM_153766.3 | ENSP00000376434.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152160Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000131 AC: 33AN: 251190 AF XY: 0.0000884 show subpopulations
GnomAD4 exome AF: 0.0000301 AC: 44AN: 1461882Hom.: 0 Cov.: 33 AF XY: 0.0000261 AC XY: 19AN XY: 727244 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152160Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74330 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Pathogenic:3
- -
Nonsense variant in the C-terminus predicted to result in protein truncation, as the last 84 amino acids are lost, and other loss-of-function variants have been reported downstream in the Human Gene Mutation Database (Stenson et al., 2014); Has not been previously published as pathogenic or benign to our knowledge -
This sequence change creates a premature translational stop signal (p.Cys308*) in the KCNJ1 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 84 amino acid(s) of the KCNJ1 protein. This variant is present in population databases (rs746509804, gnomAD 0.07%). This variant has not been reported in the literature in individuals affected with KCNJ1-related conditions. ClinVar contains an entry for this variant (Variation ID: 586076). This variant disrupts a region of the KCNJ1 protein in which other variant(s) (p.His354Serfs*8) have been determined to be pathogenic (PMID: 11318951). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. -
Bartter disease type 2 Pathogenic:2
- -
PVS1 -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at